Mardi Dier
Direttore Finanziario/CFO presso MADRIGAL PHARMACEUTICALS, INC.
Patrimonio netto: 2 M $ in data 31/05/2024
Profilo
La signora Mardi C. Dier è direttore finanziario e vicepresidente esecutivo di Ultragenyx Pharmaceutical, Inc., direttore indipendente di Oric Pharmaceuticals, Inc. e direttore indipendente di Adamas Pharmaceuticals, Inc. Fa parte del Consiglio di amministrazione di Prelude Therapeutics, Inc., Oric Pharmaceuticals, Inc. e Adamas Pharmaceuticals, Inc. La sig.ra Dier è stata precedentemente impiegata come CFO, Chief Business Officer & Executive VP di Portola Pharmaceuticals, Inc., Vice President-Investor Relations di Chiron Corp., Director-Investment Banking di Prudential Equity Group LLC, Senior Accountant di KPMG LLP, Senior Accountant di KPMG Peat Marwick LLP e Director-Investment Banking di Prudential Securities. È stata anche membro del consiglio di amministrazione del Jewish Vocational Service, Inc. e del Futures Strategic Trust. Si è laureata alla Stanford University e ha conseguito un MBA alla UCLA Anderson School of Management.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 11/03/2024 | 8 875 ( 0.04% ) | 2 M $ | 31/05/2024 | |
| 14/06/2024 | 10 000 ( 0.02% ) | 38 500 $ | 31/05/2024 | |
ACELYRIN, INC.
0.01% | 09/05/2023 | 7 306 ( 0.01% ) | 30 101 $ | 31/05/2024 |
ORIC PHARMACEUTICALS INC
-.--% | 12/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Mardi Dier
| Società | Posizione | Inizio |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 02/03/2020 |
| PRELUDE THERAPEUTICS INCORPORATED | Direttore/Membro del Consiglio | 01/08/2020 |
| MADRIGAL PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 11/03/2024 |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Consulente / Consigliere | - |
Synthekine, Inc.
 Synthekine, Inc. BiotechnologyHealth Technology Synthekine, Inc. engages as a biotechnology company. The company is headquartered in Menlo Park, CA. | Direttore/Membro del Consiglio | 03/06/2021 |
Precedenti posizioni note di Mardi Dier
| Società | Posizione | Fine |
|---|---|---|
| ACELYRIN, INC. | Direttore Finanziario/CFO | 02/08/2023 |
| ULTRAGENYX PHARMACEUTICAL INC. | Direttore Finanziario/CFO | 15/11/2022 |
| ADAMAS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 09/06/2021 |
| PORTOLA PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 01/07/2020 |
| ░░░░░░ ░░░░░ | ░░░░░░░░ ░░░░░░░░░ ░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Mardi Dier
| UCLA Anderson School of Management | Masters Business Admin |
| Stanford University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| ORIC PHARMACEUTICALS, INC. | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| ACELYRIN, INC. | Health Technology |
| MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 11 |
|---|---|
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
| Futures Strategic Trust | Finance |
| KPMG Peat Marwick LLP | Commercial Services |
Prudential Equity Group LLC
 Prudential Equity Group LLC Investment Banks/BrokersFinance A unit of Prudential Financial, Inc. (NYSE: PRU), Prudential Equity Group LLC is a broker/dealer headquartered in New York City with additional offices in Chicago, Kansas City, Missouri, Menlo Park, California and San Francisco. The firm provides indpendent equity research, sales and trading to domestic and international institutional clients | Finance |
Jewish Vocational Service, Inc.
 Jewish Vocational Service, Inc. Miscellaneous Commercial ServicesCommercial Services Jewish Vocational Service, Inc. operates as a non-profit organization which provides educational and vocational services. It offers education, career services, workforce development, and community services. The company was founded in 1938 and is headquartered in Boston, MA. | Commercial Services |
| Prudential Securities | Finance |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
Synthekine, Inc.
Synthekine, Inc. BiotechnologyHealth Technology Synthekine, Inc. engages as a biotechnology company. The company is headquartered in Menlo Park, CA. | Health Technology |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Finance |
- Borsa valori
- Insiders
- Mardi Dier
